North America Drug Delivery Devices Industry, Trends and Forecasts to 2017

• Publication date: May 2011

The report provides value (USD million) data for all the industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants. Scope of the Research ...

The report provides value (USD million) data for all the industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants.


Scope of the Research

- Countries covered include Canada and United States.
- Industry size and market share data for Drug Delivery Devices industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized industry revenues (USD million) data for each of the industry categories in each of the country. Data from 2003 to 2010, projection forward for 7 years to 2017.
- 2010 industry player shares and distribution shares data for each of the industry categories and countries.
- Global corporate-level profiles of key industry players operating within the North America Drug Delivery Devices industry ..
- Key Companies covered include GlaxoSmithKline plc, Hospira, Inc., CareFusion Corporation, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc. and others.

Reasons to buy

- Develop innovative strategies by selecting the key market segment expected to grow .
- Develop successful market-entry strategies .
- Understand and respond to your competition by identifying who-stands-where in the North America Drug Delivery Devices competitive landscape.
- Facilitate better investment decision making by identifying the key industry sectors expected to register strong growth in the near future.
- What are the best distribution channels and what’s the most preferred mode of product distribution – Identify, understand and decide.

Drug Delivery Technology Industry in Canada

1 Table of Contents

I Table of Contents 2
I. 1 List of Data tables 8
I. 2 List of Charts 10

II Introduction 11
II. 1 About this Report and the Author 11

III Drug Delivery Devices in North America 12
III. 1 Drug Delivery Devices Cross Country Comparison, Sales (USD Million), from 2003 to 2017 12
III. 2 Drug Delivery Devices, North America, Overall Sales (USD Million), from 2003 to 2017 13
III. 3 Drug Delivery Devices, North America, Segment Volume (Units), from 2003 to 2017 20
III. 4 Drug Delivery Devices, North America, Firms share (2009-2010) 25

IV Drug Delivery Devices In United States 27
IV. 1 Drug Delivery Devices, United States, Overall Sales (USD Million), from 2003 to 2017 27
IV. 2 Drug Delivery Devices, United States, Segment Volume (Units), from 2003 to 2017 33
IV. 3 Drug Delivery Devices, United States, Distribution Channel (2009-2010) 38
IV. 3.1 Central Venous Catheters, United States, Distribution Channel (2009-2010) 38
IV. 3.2 Infusion Systems, United States, Distribution Channel (2009-2010) 38
IV. 3.3 Metered Dose Inhaler Devices, United States, Distribution Channel (2009-2010) 39
IV. 3.4 Needle Free Injections, United States, Distribution Channel (2009-2010) 39
IV. 4 Drug Delivery Devices, United States, Market Shares (2009-2010) 40
IV. 4.1 Drug Delivery Devices, United States, Market Shares (2009-2010) 40
IV. 4.2 Central Venous Catheters, United States, Market Shares (2009-2010) 42
IV. 4.3 Infusion Systems, United States, Market Shares (2009-2010) 44
IV. 4.4 Metered Dose Inhaler Devices, United States, Market Shares (2009-2010) 46
IV. 4.5 Needle Free Injections, United States, Market Shares (2009-2010) 47

V Drug Delivery Devices In Canada 49
V. 1 Drug Delivery Devices, Canada, Overall Sales (USD Million), from 2003 to 2017 49
V. 2 Drug Delivery Devices, Canada, Segment Volume (Units), from 2003 to 2017 55
V. 3 Drug Delivery Devices, Canada, Distribution Channel (2009-2010) 60
V. 3.1 Central Venous Catheters, Canada, Distribution Channel (2009-2010) 60
V. 3.2 Infusion Systems Canada, Distribution Channel (2009-2010) 60
V. 3.3 Metered Dose Inhaler Devices Canada, Distribution Channel (2009-2010) 61
V. 3.4 Needle Free Injections Canada, Distribution Channel (2009-2010) 61
V. 4 Drug Delivery Devices, Canada, Market Shares (2009-2010) 62
V. 4.1 Drug Delivery Devices, Canada, Market Shares (2009-2010) 62
V. 4.2 Central Venous Catheters, Canada, Market Shares (2009-2010) 64
V. 4.3 Infusion Systems, Canada, Market Shares (2009-2010) 66
V. 4.4 Metered Dose Inhaler Devices, Canada, Market Shares (2009-2010) 68
V. 4.5 Needle Free Injections, Canada, Market Shares (2009-2010) 69

VI Overview of Key Firms in North America Drug Delivery Devices March ket 71
VI. 1 GlaxoSmithKline plc 71
VI. 1.1 Company Profile 71
VI. 1.2 Share in the North America Drug Delivery Devices March ket 71
VI. 2 Hospira, Inc. 72
VI. 2.1 Company Profile 72
VI. 2.2 Share in the North America Drug Delivery Devices March ket 72
VI. 3 CareFusion Corporation 73
VI. 3.1 Company Profile 73
VI. 3.2 Share in the North America Drug Delivery Devices March ket 73
VI. 4 Boehringer Ingelheim GmbH 74
VI. 4.1 Company Profile 74
VI. 4.2 Share in the North America Drug Delivery Devices March ket 74
VI. 5 AstraZeneca PLC 75
VI. 5.1 Company Profile 75
VI. 5.2 Share in the North America Drug Delivery Devices March ket 75
VI. 6 Baxter International Inc. 76
VI. 6.1 Company Profile 76
VI. 6.2 Share in the North America Drug Delivery Devices March ket 76
VI. 7 Medtronic, Inc. 77
VI. 7.1 Company Profile 77
VI. 8 Teleflex Incorporated 77
VI. 8.1 Company Profile 77
VI. 9 Smiths Medical 77
VI. 9.1 Company Profile 77
VI. 10 Fresenius Kabi AG 78
VI. 10.1 Company Profile 78
VI. 11 B. Braun Melsungen AG 78
VI. 11.1 Company Profile 78
VI. 12 Terumo Corporation 78
VI. 12.1 Company Profile 78
VI. 13 3M Health Care 79
VI. 13.1 Company Profile 79
VI. 14 Consort Medical plc 79
VI. 14.1 Company Profile 79
VI. 15 Edwards Lifesciences Corporation 79
VI. 15.1 Company Profile 79
VI. 16 Becton, Dickinson and Firms 80
VI. 16.1 Company Profile 80
VI. 17 Codman & Shurtleff, Inc. 80
VI. 17.1 Company Profile 80
VI. 18 JMS CO., LTD. 80
VI. 18.1 Company Profile 80
VI. 19 Cook Medical Incorporated 81
VI. 19.1 Company Profile 81
VI. 20 INJEX - Equidyne Systems 81
VI. 20.1 Company Profile 81
VI. 21 Antares Pharma, Inc. 81
VI. 21.1 Company Profile 81
VI. 22 Bioject Medical Technologies Inc. 82
VI. 22.1 Company Profile 82

VII Drug Delivery Devices March ket Pipeline Products 83

VIII Financial Deals Landscape 87
VIII. 1 Acquisition 87
VIII. 1.1 CarePoint Partners Takes Over Premier Infusion 87
VIII. 1.2 SurModics Plans The Sale Of SurModics Pharmaceuticals 88
VIII. 1.3 BTG International To Take Over Biocompatibles 89
VIII. 1.4 Nordson Completes Acquisition Of Micromedics 91
VIII. 1.5 Cardinal Health Sells 13.7% Stake In Carefusion 92
VIII. 1.6 Cellectis Takes Over Cyto Pulse Sciences 93
VIII. 2 Partner agreements 94
VIII. 2.1 InfuSystem Enters Into Distribution Agreement With Poppy Pocket 94
VIII. 2.2 Radius Healthe Enters Into Collaboration Agreement With 3M Drug Delivery Systems 95
VIII. 2.3 Eli Lilly Enters Into Collaboration With Medtronic 96
VIII. 2.4 West Pharmaceutical Enters Into Agreement With CareFusion 97
VIII. 2.5 Nile Therapeutics Concludes a New Deal With Medtronic 98
VIII. 2.6 Hospira Concludes a New Deal With Smiths Medical 99

IX Recent Developments 100
IX. 1 Company Vision and Strategy 100
IX. 1.1 November 01, 2010: HepaLife Launches Alliqua To Focus On Development, Manufacturing And March keting Of Proprietary Transdermal Drug Delivery Products 100
IX. 1.2 October 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 101
IX. 1.3 August 31, 2010: Vetter Opens New Sales Office At Illinois Science + Technology Park In Suburban Chicago 102
IX. 1.4 August 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey 102
IX. 1.5 August 10, 2010: CareFusion Announces Firms -Wide Restructuring 103
IX. 1.6 July 14, 2010: GE Healthcare To Shut Down Two Offices In Waukesha 103
IX. 1.7 July 01, 2010: Shionogi Announces Reorganization Of US Operations 103
IX. 1.8 June 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 104
IX. 2 Legal and Regulatory 104
IX. 2.1 May 04, 2011: B. Braun Prevails In Case Against Terumo For Introcan Safety IV Catheter Patent 104
IX. 2.2 April 07, 2011: Tekmira Comments On Answer And Counterclaim Filed By Alnylam 104
IX. 2.3 March 16, 2011: Tekmira Sues Alnylam Pharmaceuticals For Repeated Misuse Of Trade Secrets And Confidential Information 105
IX. 2.4 February 11, 2011: University Of Florida Research Foundation Initiates Court Case Against Diamyd Medical 106
IX. 2.5 November 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter 106
IX. 2.6 November 09, 2010: Greenberg Traurig And Segal McCambridge Singer & MahoneyObtain Three Defense Verdicts For I-Flow In Oregon Infusion Pump Cases 106
IX. 2.7 November 03, 2010: Protein Sciences Reports Settlement With Emergent BioSolutions 106
IX. 2.8 September 03, 2010: BioSphere Agrees To Settle Suit Over Merit Medical merger 107
IX. 2.9 July 30, 2010: Federal Appeals Court Rules In Favor Of Covidien In Needle Patents Suit 107
IX. 2.10 July 23, 2010: BioSphere Names In Class Action By Shareholders: SEC Filing 107
IX. 2.11 June 10, 2010: I-Flow Resolves Patent Infringement, Trade Secret Litigation Against Apex Medical Technologies, Zone Medical 108
IX. 3 Government and Public Interest 108
IX. 3.1 May 12, 2011: GlaxoSmithKline And Gilead Sciences AIDS Drugs Cut Transmission To Partners By 96%, Study Shows 108
IX. 3.2 April 13, 2011: MannKind’s End-Of-Review Meeting With FDA Rescheduled 109
IX. 3.3 April 08, 2011: MannKind Provides Regulatory Update 109
IX. 3.4 March 16, 2011: Syracuse University Scientists Develop New Drug Delivery System To Improve Cancer Treatment 110
IX. 3.5 February 17, 2011: Delcath Achieves ISO 13485 Certification 110
IX. 3.6 December 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 111
IX. 3.7 October 26, 2010: GERES Study Confirms Passive Safety Devices Are Most Effective In Needlestick Injury Prevention 111
IX. 3.8 August 31, 2010: Purdue University Researchers Develop New Pump For Microneedle Drug-Delivery Patch 112
IX. 3.9 August 24, 2010: Canada Invests In Health Research 113
IX. 3.10 August 09, 2010: Talecris Biotherapeutics And Grifols Receive FTC Request For Additional Information Regarding Proposed Merger 114
IX. 3.11 June 14, 2010: Electronic Cigarettes Are Drug Delivery Devices And Should Be Subject To FDA Regulations: AMA 115
IX. 4 Product News 115
IX. 4.1 November 02, 2010: Innovotech Testing Contributes To FDA March ket Clearance For Teleflex' ArrowEVOLUTION Anti-Microbial Coated Catheter 115
IX. 4.2 July 27, 2010: Dentistry Today Selects Milestone’s STA Single Tooth Anesthesia System For Top 100 Products Award Program 115
IX. 4.3 July 13, 2010: Baxter Announces Final Details Regarding Previously Communicated COLLEAGUE Infusion Pump Recall In US 116
IX. 4.4 July 08, 2010: Bioject Announces Use Of Its Intradermal Needle-Free Delivery System In World Health Organization Clinical Trial In Oman With Poliovirus Vaccine 117
IX. 4.5 May 03, 2010: Baxter To Recall COLLEAGUE Infusion Pumps In US 118

X Appendix 119
X. 1 Definitions of March kets Covered in the Report 120
X. 1.1 Drug Delivery Devices 120
X. 2 Research Methodology 121
X. 3 Secondary Research 121
X. 4 Primary Research 122
X. 5 Models 122
X. 6 Forecasted data s 123
X. 7 Expert Panels 123
X. 8 GlobalData Consulting 123
X. 9 Currency Conversion 123
X. 10 Contact Us 124
X. 11 Disclaimer 124

1.1

List of Tables


Data table 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 12
Data table 2: Drug Delivery Devices, North America, Overall Sales (USD Million), from 2003 to 2017 14
Data table 3: Drug Delivery Devices, North America, Cross-Category Analysis, from 2003 to 2017 15
Data table 4: Drug Delivery Devices, North America, Overall Sales (USD Million), Historical data, from 2003 to 2010 17
Data table 5: Drug Delivery Devices, North America, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 19
Data table 6: Drug Delivery Devices, North America, Segment Volume (Units), from 2003 to 2017 20
Data table 7: Drug Delivery Devices, North America, Segment Volume (Units), Historical data, from 2003 to 2010 22
Data table 8: Drug Delivery Devices, North America, Segment Volume (Units), Forecasted data, from 2010 to 2017 24
Data table 9: Drug Delivery Devices, North America, Firms share by Sales (USD Million), from 2009 to 2010 26
Data table 10: Drug Delivery Devices, United States, Overall Sales (USD Million), from 2003 to 2017 28
Data table 11: Drug Delivery Devices, United States, Overall Sales (USD Million), Historical data, from 2003 to 2010 30
Data table 12: Drug Delivery Devices, United States, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 32
Data table 13: Drug Delivery Devices, United States, Segment Volume (Units), from 2003 to 2017 33
Data table 14: Drug Delivery Devices, United States, Segment Volume (Units), Historical data, from 2003 to 2010 35
Data table 15: Drug Delivery Devices, United States, Segment Volume (Units), Forecasted data, from 2010 to 2017 37
Data table 16: Central Venous Catheters, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 38
Data table 17: Infusion Systems, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 38
Data table 18: Metered Dose Inhaler Devices, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 39
Data table 19: Needle Free Injections, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 39
Data table 20: Drug Delivery Devices, United States, Market Shares by Sales (USD Million), from 2009 to 2010 41
Data table 21: Central Venous Catheters, United States, Market Shares by Sales (USD Million), from 2009 to 2010 43
Data table 22: Infusion Systems, United States, Market Shares by Sales (USD Million), from 2009 to 2010 45
Data table 23: Metered Dose Inhaler Devices, United States, Market Shares by Sales (USD Million), from 2009 to 2010 46
Data table 24: Needle Free Injections, United States, Market Shares by Sales (USD Million), from 2009 to 2010 48
Data table 25: Drug Delivery Devices, Canada, Overall Sales (USD Million), from 2003 to 2017 50
Data table 26: Drug Delivery Devices, Canada, Overall Sales (USD Million), Historical data, from 2003 to 2010 52
Data table 27: Drug Delivery Devices, Canada, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 54
Data table 28: Drug Delivery Devices, Canada, Segment Volume (Units), from 2003 to 2017 55
Data table 29: Drug Delivery Devices, Canada, Segment Volume (Units), Historical data, from 2003 to 2010 57
Data table 30: Drug Delivery Devices, Canada, Segment Volume (Units), Forecasted data, from 2010 to 2017 59
Data table 31: Central Venous Catheters, Canada, Distribution Channel by Sales (USD Million), from 2009 to 2010 60
Data table 32: Infusion Systems, Canada, Distribution Channel by Sales (USD Million), from 2009 to 2010 60
Data table 33: Metered Dose Inhaler Devices, Canada, Distribution Channel by Sales (USD Million), from 2009 to 2010 61
Data table 34: Needle Free Injections, Canada, Distribution Channel by Sales (USD Million), from 2009 to 2010 61
Data table 35: Drug Delivery Devices, Canada, Market Shares by Sales (USD Million), from 2009 to 2010 63
Data table 36: Central Venous Catheters, Canada, Market Shares by Sales (USD Million), from 2009 to 2010 65
Data table 37: Infusion Systems, Canada, Market Shares by Sales (USD Million), from 2009 to 2010 67
Data table 38: Metered Dose Inhaler Devices, Canada, Market Shares by Sales (USD Million), from 2009 to 2010 68
Data table 39: Needle Free Injections, Canada, Market Shares by Sales (USD Million), from 2009 to 2010 70
Data table 40: Drug Delivery Devices March ket Pipeline Products 83
Data table 41: CarePoint Partners Takes Over Premier Infusion 87
Data table 42: SurModics Plans The Sale Of SurModics Pharmaceuticals 88
Data table 43: BTG International To Take Over Biocompatibles 89
Data table 44: Nordson Completes Acquisition Of Micromedics 91
Data table 45: Cardinal Health Sells 13.7% Stake In Carefusion 92
Data table 46: Cellectis Takes Over Cyto Pulse Sciences 93
Data table 47: InfuSystem Enters Into Distribution Agreement With Poppy Pocket 94
Data table 48: Radius Healthe Enters Into Collaboration Agreement With 3M Drug Delivery Systems 95
Data table 49: Eli Lilly Enters Into Collaboration With Medtronic 96
Data table 50: West Pharmaceutical Enters Into Agreement With CareFusion 97
Data table 51: Nile Therapeutics Concludes a New Deal With Medtronic 98
Data table 52: Hospira Concludes a New Deal With Smiths Medical 99
Data table 53: US Dollar to Local Currency, North America, Average Exchange Rate from 2003 to 2010 123

1.2

List of Figures


Chart 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 12
Chart 2: Drug Delivery Devices, North America, Overall Sales (USD Million), from 2003 to 2017 13
Chart 3: Drug Delivery Devices, North America, Cross-Category Analysis, from 2003 to 2017 15
Chart 4: Drug Delivery Devices, North America, Overall Sales (USD Million), Historical data, from 2003 to 2010 16
Chart 5: Drug Delivery Devices, North America, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 18
Chart 6: Drug Delivery Devices, North America, Segment Volume (Units), from 2003 to 2017 20
Chart 7: Drug Delivery Devices, North America, Segment Volume (Units), Historical data, from 2003 to 2010 21
Chart 8: Drug Delivery Devices, North America, Segment Volume (Units), Forecasted data, from 2010 to 2017 23
Chart 9: Drug Delivery Devices, North America, Firms share (%), 2010 25
Chart 10: Drug Delivery Devices, United States, Overall Sales (USD Million), from 2003 to 2017 27
Chart 11: Drug Delivery Devices, United States, Overall Sales (USD Million), Historical data, from 2003 to 2010 29
Chart 12: Drug Delivery Devices, United States, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 31
Chart 13: Drug Delivery Devices, United States, Segment Volume (Units), from 2003 to 2017 33
Chart 14: Drug Delivery Devices, United States, Segment Volume (Units), Historical data, from 2003 to 2010 34
Chart 15: Drug Delivery Devices, United States, Segment Volume (Units), Forecasted data, from 2010 to 2017 36
Chart 16: Drug Delivery Devices, United States, Market Shares (%), 2010 40
Chart 17: Central Venous Catheters, United States, Market Shares (%), 2010 42
Chart 18: Infusion Systems, United States, Market Shares (%), 2010 44
Chart 19: Metered Dose Inhaler Devices, United States, Market Shares (%), 2010 46
Chart 20: Needle Free Injections, United States, Market Shares (%), 2010 47
Chart 21: Drug Delivery Devices, Canada, Overall Sales (USD Million), from 2003 to 2017 49
Chart 22: Drug Delivery Devices, Canada, Overall Sales (USD Million), Historical data, from 2003 to 2010 51
Chart 23: Drug Delivery Devices, Canada, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 53
Chart 24: Drug Delivery Devices, Canada, Segment Volume (Units), from 2003 to 2017 55
Chart 25: Drug Delivery Devices, Canada, Segment Volume (Units), Historical data, from 2003 to 2010 56
Chart 26: Drug Delivery Devices, Canada, Segment Volume (Units), Forecasted data, from 2010 to 2017 58
Chart 27: Drug Delivery Devices, Canada, Market Shares (%), 2010 62
Chart 28: Central Venous Catheters, Canada, Market Shares (%), 2010 64
Chart 29: Infusion Systems, Canada, Market Shares (%), 2010 66
Chart 30: Metered Dose Inhaler Devices, Canada, Market Shares (%), 2010 68
Chart 31: Needle Free Injections, Canada, Market Shares (%), 2010 69
Chart 32: GlaxoSmithKline plc, Market Shares (%), North America Drug Delivery Devices March ket, 2010 71
Chart 33: Hospira, Inc., Market Shares (%), North America Drug Delivery Devices March ket, 2010 72
Chart 34: CareFusion Corporation, Market Shares (%), North America Drug Delivery Devices March ket, 2010 73
Chart 35: Boehringer Ingelheim GmbH, Market Shares (%), North America Drug Delivery Devices March ket, 2010 74
Chart 36: AstraZeneca PLC, Market Shares (%),North America Drug Delivery Devices March ket, 2010 75
Chart 37: Baxter International Inc., Market Shares (%), North America Drug Delivery Devices March ket, 2010 76

Companies Mentioned
GlaxoSmithKline plc
Hospira, Inc.
CareFusion Corporation
Boehringer Ingelheim GmbH
AstraZeneca PLC
Baxter International Inc.
Medtronic, Inc.
Teleflex Incorporated
Smiths Medical
Fresenius Kabi AG
B. Braun Melsungen AG
Terumo Corporation
3M Health Care
Consort Medical plc
Edwards Lifesciences Corporation
Becton, Dickinson and Firms
Codman & Shurtleff, Inc.
JMS CO., LTD.
Cook Medical Incorporated
INJEX - Equidyne Systems
Antares Pharma, Inc.
Bioject Medical Technologies Inc.